SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-018324
Filing Date
2023-11-09
Accepted
2023-11-08 17:35:44
Documents
94
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q akya-20230930x10q.htm   iXBRL 10-Q 2328565
2 EX-31.1 akya-20230930xex31d1.htm EX-31.1 14851
3 EX-31.2 akya-20230930xex31d2.htm EX-31.2 14890
4 EX-32.1 akya-20230930xex32d1.htm EX-32.1 6817
5 EX-32.2 akya-20230930xex32d2.htm EX-32.2 7821
  Complete submission text file 0001558370-23-018324.txt   9752106

Data Files

Seq Description Document Type Size
6 EX-101.SCH akya-20230930.xsd EX-101.SCH 61936
7 EX-101.CAL akya-20230930_cal.xml EX-101.CAL 74745
8 EX-101.DEF akya-20230930_def.xml EX-101.DEF 236657
9 EX-101.LAB akya-20230930_lab.xml EX-101.LAB 544304
10 EX-101.PRE akya-20230930_pre.xml EX-101.PRE 421522
88 EXTRACTED XBRL INSTANCE DOCUMENT akya-20230930x10q_htm.xml XML 1894865
Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Filer) CIK: 0001711933 (see all company filings)

IRS No.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40344 | Film No.: 231389393
SIC: 3826 Laboratory Analytical Instruments